acetylglucosamine has been researched along with B16 Melanoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Antolíková, M; Bezouska, K; Bílý, J; Hofbauerová, K; Ivanová, L; Kavan, D; Kovalová, A; Kren, V; Kubícková, M; Kubínková, Z; Ledvina, M; Libigerová, M; Mrázek, H; Pompach, P; Rozbeský, D; Saman, D; Sklenár, V; Vanek, O; Zídek, L; Zyka, D | 1 |
| Chen, WR; Christopher Garcia, K; Davis, MM; Hildebrand, WH; Hoover, AR; Kaabinejadian, S; Krawic, JR; Naqash, AR; Sun, XH; Yang, X; Yin, Q | 1 |
| Adams, DJ; Bansal, V; Kadari, A; Kulhari, H; Pooja, D; Sistla, R; Srinivasa Reddy, T | 1 |
| Benson, V; Fiserova, A; Grobarova, V; Hulikova, K; Svoboda, J | 1 |
| Barthel, SR; Cedeno-Laurent, F; Dimitroff, CJ; Frank, MH; Hays, D; He, X; Matta, KL; Murphy, GF; Opperman, MJ; Schatton, T; Supko, JG; Zhan, Q | 1 |
| Bezouska, K; Fiserová, A; Horváth, O; Kren, V; Krist, P; Kuldová, M; Lindhorst, TK; Luptovcová, M; Mosca, F; Pospísil, M; Rossmann, P; Sadalapure, K; Vannucci, L | 1 |
| Gu, J; Honke, K; Isaji, T; Miyoshi, E; Nishiuchi, R; Sekiguchi, K; Takahashi, M; Taniguchi, N; Zhao, Y | 1 |
| Inoue, S; Matsuzawa, Y; Nishiura, T; Ogawa, M; Okajima, Y; Oritani, K; Sheng, Y; Taniguchi, N; Yoshida, H; Yoshimura, M | 1 |
| Ido, T; Ishiwata, K; Iwata, R; Kimata, K; Kubota, K; Kubota, R; Sato, K; Tada, M; Yamada, S | 1 |
9 other study(ies) available for acetylglucosamine and B16 Melanoma
| Article | Year |
|---|---|
Synthetic N-acetyl-D-glucosamine based fully branched tetrasaccharide, a mimetic of the endogenous ligand for CD69, activates CD69+ killer lymphocytes upon dimerization via a hydrophilic flexible linker.
Topics: Acetylglucosamine; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Carbohydrate Sequence; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Natural; Lectins, C-Type; Ligands; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Mimicry; Molecular Sequence Data; NK Cell Lectin-Like Receptor Subfamily B; Oligosaccharides; Rats; Recombinant Proteins | 2010 |
Localized ablative immunotherapy drives de novo CD8
Topics: Acetylglucosamine; Animals; Antigens, Neoplasm; CD8-Positive T-Lymphocytes; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 2022 |
N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery.
Topics: A549 Cells; Acetylglucosamine; Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Dendrimers; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 2020 |
N-acetyl-D-glucosamine-coated polyamidoamine dendrimer promotes tumor-specific B cell responses via natural killer cell activation.
Topics: Acetylglucosamine; Animals; Antibody-Dependent Cell Cytotoxicity; B-Lymphocytes; B7-1 Antigen; B7-2 Antigen; Cell Line, Tumor; Dendrimers; Female; Immunoglobulin G; Interferon-gamma; Interleukin-4; Killer Cells, Natural; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Up-Regulation | 2011 |
Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.
Topics: Acetylglucosamine; Amino Sugars; Animals; Galectin 1; Interferon-gamma; Interleukin-10; Leukosialin; Lymphoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic | 2012 |
Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo.
Topics: Acetylglucosamine; Animals; Antigens, CD; Antigens, Surface; Biocompatible Materials; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Cytotoxicity, Immunologic; Dendrimers; Dose-Response Relationship, Drug; Fluorescent Dyes; Glycoconjugates; Killer Cells, Natural; Lectins, C-Type; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NK Cell Lectin-Like Receptor Subfamily B; Polyamines; Recombinant Proteins; Tumor Cells, Cultured | 2003 |
Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.
Topics: Acetylglucosamine; Animals; Biotinylation; Blotting, Western; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glycosylation; HeLa Cells; Humans; Integrin alpha2beta1; Integrin alpha3beta1; Integrin alpha5beta1; Integrins; Lectins; Ligands; Liposomes; Melanoma, Experimental; Mice; Models, Biological; N-Acetylglucosaminyltransferases; Phosphorylation; Precipitin Tests; Protein Binding; Protein-Tyrosine Kinases; Transfection; Up-Regulation | 2004 |
Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing beta1,4-N-acetylglucosaminyltransferase III.
Topics: Acetylglucosamine; Animals; Antibodies, Monoclonal; Carbohydrate Sequence; Cell Adhesion; Cytotoxicity Tests, Immunologic; Female; Glycoconjugates; Glycoside Hydrolases; Hyaluronan Receptors; Hyaluronic Acid; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Monophenol Monooxygenase; N-Acetylglucosaminyltransferases; Neoplasm Transplantation; Splenic Neoplasms; Transfection; Tumor Cells, Cultured | 1997 |
Investigation of tumor metastatic potential with N-[18F]fluoroacetyl-D-glucosamine.
Topics: Acetylglucosamine; Animals; Fluorine Radioisotopes; Liver; Male; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Muscles; Neoplasm Metastasis; Time Factors; Tissue Distribution | 1992 |